신보조화학요법을 받은 삼중음성유방암 환자에서 인종/민족별 병리학적 완전 반응 및 전체 생존율의 격차

Woriax 외(Fri,)가 이 문제를 연구했습니다.

www.synapsesocial.com/papers/68e77c94b6db6435876f0e3d — DOI: https://doi.org/10.1200/jco.23.01199

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies· 2011 · 5,458 citations
2. Race, Socioeconomic Status, and Breast Cancer Treatment and Survival· 2002 · 667 citations
3. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis· 2014 · 4,658 citations
4. Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy· 2005 · 422 citations
5. Who Are the Patients in Our Clinical Trials for Cancer?· 2019 · 12 citations